Clinical trial Recruiting at 4 sites Observational Ages 18 to 80

Monitoring the performance of the GMK SpheriKA knee prosthesis

Official title: Medacta GMK® SpheriKA and Kinematic Alignment Technique Multicenter, Post-Market Outcome Study

Run by Medacta International SA · NCT05459948 · Data updated 2026-11-12

This study is testing how well the GMK SpheriKA knee prosthesis works for people getting a total knee replacement and how it helps them recover after surgery.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment281 (estimated)
SponsorMedacta International SA
Industry-sponsored
Locations4 sites (Mérignac and 3 other locations)
StatusRecruiting
StartedJuly 30, 2022
Main results expectedMay 2035
Study endsMay 2035
Registry record updatedSeptember 29, 2025
Trial IDNCT05459948 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients aged 18 to 80 who require a primary total knee replacement and have intact collateral ligaments.

Probably not a fit

Patients with inflammatory arthritis, morbid obesity, or previous knee surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect clinical and radiological data to evaluate the performance of the GMK SpheriKA knee prosthesis, which is implanted using a kinematic alignment technique. Participants will be monitored postoperatively to assess their recovery and the effectiveness of the prosthesis. The study will involve patients who are undergoing primary total knee replacement and will require their compliance with follow-up evaluations and weight-bearing restrictions.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the long-term performance and safety of the GMK SpheriKA knee prosthesis, potentially improving outcomes for knee replacement patients.

How similar studies have gone: Other studies on knee prosthesis performance have shown success, indicating that post-marketing surveillance can provide critical data for improving surgical outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients willing to sign the informed consent.
* Patients able to comply with follow-up requirements, including postoperative weight-bearing restrictions and self-evaluations.
* Patients 18 - 80 years of age at the time of surgery.
* Patients requiring a primary total knee replacement (on label use).
* Patients with intact collateral ligaments.

Exclusion Criteria:

* Patients with inflammatory arthritis.
* Morbidly obese patients, with a body mass index (BMI) \> 40.
* Patients with a history of total or unicompartmental reconstruction of the affected joint.
* Patients that have had a high tibial osteotomy or femoral osteotomy.
* Patients with neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
* Patients with a systemic or metabolic disorder leading to progressive bone deterioration.
* Patients that are immunologically compromised or receiving chronic steroids (\> 30 days).
* Patients whose bone stock is compromised due to disease or infection, unable to provide adequate support and/or fixation to the prosthesis.
* Patients with an active or suspected latent infection in or surrounding the knee joint.
* Pregnant or breastfeeding women.

Where it's running

  • Centre de l'Arthrose
    Mérignac, France
    Recruiting
  • Clinique de l'Union
    Saint-Jean, France
    Recruiting
  • Humanitas Castelli
    Bergamo, Italy
    Recruiting
  • Gelenkzentrum Winterthur
    Winterthur, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.